| Authors | Yoshihito Horisawa, Tadakazu Kondo, Masakatsu Hishizawa, Kouhei Yamashita, Akifumi Takaori-Kondo |
| Journal | Annals of hematology
(Ann Hematol)
Vol. 99
Issue 11
Pg. 2699-2701
(Nov 2020)
ISSN: 1432-0584 [Electronic] Germany |
| PMID | 32318778
(Publication Type: Case Reports, Letter)
|
| Chemical References |
- Antibodies, Monoclonal
- Antigens, Neoplasm
- Antineoplastic Agents, Immunological
- Membrane Glycoproteins
- daratumumab
- Bortezomib
- Dexamethasone
- CD38 protein, human
- ADP-ribosyl Cyclase 1
- Lenalidomide
|
| Topics |
- ADP-ribosyl Cyclase 1
(antagonists & inhibitors, immunology)
- Allografts
- Antibodies, Monoclonal
(administration & dosage)
- Antigens, Neoplasm
(immunology)
- Antineoplastic Agents, Immunological
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Bone Marrow Transplantation
- Bortezomib
(administration & dosage)
- Combined Modality Therapy
- Dexamethasone
(administration & dosage)
- Humans
- Lenalidomide
(administration & dosage)
- Leukemia, Plasma Cell
(drug therapy, therapy)
- Male
- Membrane Glycoproteins
(antagonists & inhibitors, immunology)
- Middle Aged
- Molecular Targeted Therapy
- Peripheral Blood Stem Cell Transplantation
- Remission Induction
- Salvage Therapy
- Transplantation Conditioning
- Transplantation, Autologous
|
